Particulate Contamination in Single-Dose Parenteral Antibiotics in Iran Parenteral antibiotics particulate contamination
Iranian Journal of Pharmaceutical Sciences,
Vol. 1 No. 1 (2005),
15 January 2005
,
Page 1-6
https://doi.org/10.22037/ijps.v1.39435
Abstract
In order to ensure the safety of parenterals, international pharmacopoeias and national standards have set up stringent guidelines and standards. Particulate contamination is a potential health risk caused by intravenous injection of particles large enough to potentially clog the small arteries. Particles could be produced through manufacturing and packaging or even dispensing of the pharmaceuticals.
The nature of the particles are varied and could be of drug itself, packaging debris, rubber, plastic, cotton, fiber and glass particles, which might be produced during the breakage of an ampoule. In this study, some of the small volume parenterals available in Iranian drug market have been investigated for the presence of particles.
Although, most of the tested samples passed national standard tests for particulate contamination of small volume parenterals, 40% of the samples were
rejected using the same protocols. Therefore, it appears that particulate contamination of parenterals creates an additional source of risk for patients who receive these medications, intravenously.
- Parenterals
- Particulate contamination
- Particle size
How to Cite
References
[2] Steffens KJ. Parenterale therapie und fremdpartikeln. Pharm Ind 1990; 52: 1539.
[3] Turco S, Davis N. Clinical significance of particulate matter, a review of the literature. Hosp Pharm 1973; 8: 137.
[4] Van Der Veen J, Verbrugge Ph, Van De Vaart FJ, Boom FA. Particulate matter determination in LVPs produced in dutch hospital pharmacies, part 1: particle ounting accuracy. PDA J Pharm Sci Tech 1997; 51: 81.
[5] Boom FA, Van Der Veen J, Verbrugge PH, Van Der Vaart FJ, Paalman ACA, Vos TH. Particulate matter determination in LVPs produced in dutch hospital pharmacies, part 2: overview of the results. PDA J Pharm Sci Tech 2000; 54: 343.
[6] Turco S, Davis N. Preventing the injection of glass particles with furosemide solution. Hosp Pharm 1972; 7: 423.
[7] Carbone-Trader KB, Shanks CA. Glass particle contamination in single-dose ampoules. Anesth Analg 1986; 65: 1361.
[8] Shaw NJ, Lyall EG. Hazards of glass ampoules. Brit Med J 1985; 291: 1390.
[9] Particulate matter in injection. In: United State Pharmacopoeia. 27th ed. United States Pharmacopeal Convention INC., Rockville, Maryland. 2004; pp. 1971.
[10] Parenteral preparations. In: British Pharmacopoeia. Stationary Office, Department of Health, London. 1999; pp. 1575.
[11] Particulate contamination: visible particles. In: European Pharmacopoeia. 4th ed. 2002; p. 222.
[12] Standard Operation Procedure (SOP) for visual examination of parenterals. National Food and Control Lab, Iran Ministry of Health, Tehran. 2002.
[13] DAC-probe 5. Visual examination on particles of parenteral. In: German Drug Codex (DAC) 1999.
[14] Timothy, J. Intravenous filters, panacea or placebo? J Clin Nurs 1996; 5: 3-6.
[15] Giambrone AJ. Two methods of single-dose ampule opening and their influence upon glass particulate contamination. J Am Ass Nurse Anesth 1991; 59: 225.
[16] Drucker E. The injection century: massive unsterile injection and the emergence of pathogens. Lancet 2001; 358: 1991.
[17] Miller MA, Pisani E. The cost of unsafe injections. Bull WHO 1999; 77: 808.
[18] Waller DG, George CF. Ampoules, infusions and filters. Brit Med J 1985; 292: 714.
[19] Newall F, Ranson K, Robertson J. Use of in-line filters in pediatric intravenous therapy. J Intraven Nurs 1998; 21: 166.
- Abstract Viewed: 622 times
- IJPS_Volume 1_Issue 1_Pages 1-6 Downloaded: 196 times